Payment overview · 2025
General Payments
$2,383.43
66 reported records · 20 companies
Healthcare provider profile · identity verified
Houman Tamaddon, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · AUGUSTA, GA · NPI 1609096585
Verified facts
What the public records show
CMS Open Payments records show Houman Tamaddon, M.D. received $2,383.43 in general payments during 2025 across 66 reported records.
Endologix LLC accounted for 28.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 33 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Endologix LLC | Unresolved — no canonical attribution shown | $689.49 | 28.9% | 3 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $437.21 | 18.3% | 19 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $340.50 | 14.3% | 15 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $249.65 | 10.5% | 6 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $103.08 | 4.3% | 3 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $90.21 | 3.8% | 3 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $86.93 | 3.6% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $60.86 | 2.5% | 3 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $56.75 | 2.4% | 2 | 2025 |
| Davol Inc. | Unresolved — no canonical attribution shown | $48.85 | 2.0% | 1 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $40.52 | 1.7% | 1 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $28.38 | 1.2% | 1 | 2025 |
| Getinge USA Sales, LLC | Unresolved — no canonical attribution shown | $27.38 | 1.1% | 1 | 2025 |
| Solventum Corporation | Unresolved — no canonical attribution shown | $24.48 | 1.0% | 1 | 2025 |
| ARGON MEDICAL DEVICES, INC. | Unresolved — no canonical attribution shown | $21.40 | 0.9% | 1 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $18.00 | 0.8% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $17.10 | 0.7% | 1 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $15.43 | 0.7% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$14.45 | 0.6% | 1 | 2025 |
| Flowphysix Inc | Unresolved — no canonical attribution shown | $12.76 | 0.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $2,383.43 | 66 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $583.08 | 2 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $267.38 | 3 | 2025 |
Source payment records
|
|||||
| GRAFIX PL Normalized: grafix pl |
Biological | Smith+Nephew, Inc. | $229.69 | 5 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $182.30 | 10 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $158.20 | 5 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $106.41 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $86.93 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $86.93 | 1 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $67.89 | 2 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $67.89 | 2 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $67.39 | 2 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $60.86 | 3 | 2025 |
Source payment records
|
|||||
| Progel Applicator Spray Tips Normalized: progel applicator spray tips |
Device | Davol Inc. | $48.85 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH ALPHA Normalized: zenith alpha |
Device | Cook Medical LLC | $48.55 | 3 | 2025 |
Source payment records
|
|||||
| COOK Normalized: cook |
Device | Cook Medical LLC | $42.78 | 5 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $40.52 | 1 | 2025 |
Source payment records
|
|||||
| ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM Normalized: icast covered stent system 6mmx22mmx120cm |
Device | Cook Medical LLC | $40.01 | 2 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $35.19 | 1 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $34.84 | 1 | 2025 |
Source payment records
|
|||||
| CARDIOSAVE RESCUE Normalized: cardiosave rescue |
Device | Getinge USA Sales, LLC | $27.38 | 1 | 2025 |
Source payment records
|
|||||
| PREVENA Normalized: prevena |
Device | Solventum Corporation | $24.48 | 1 | 2025 |
Source payment records
|
|||||
| V.A.C. GRANUFOAM Normalized: v a c granufoam |
Device | Solventum Corporation | $24.48 | 1 | 2025 |
Source payment records
|
|||||
| V.A.C. VERAFLO CLEANSE CHOICE Normalized: v a c veraflo cleanse choice |
Device | Solventum Corporation | $24.48 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH Normalized: zenith |
Device | Cook Medical LLC | $24.15 | 4 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $22.82 | 1 | 2025 |
Source payment records
|
|||||
| ALPHAVAC Normalized: alphavac |
Device | AngioDynamics, Inc. | $21.91 | 1 | 2025 |
Source payment records
|
|||||
| CLOT MANAGEMENT Normalized: clot management |
Device | ARGON MEDICAL DEVICES, INC. | $21.40 | 1 | 2025 |
Source payment records
|
|||||
| STRAVIX PL Normalized: stravix pl |
Biological | Smith+Nephew, Inc. | $19.96 | 1 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $18.00 | 1 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $17.10 | 1 | 2025 |
Source payment records
|
|||||
| CLOSURERFS Normalized: closurerfs |
Device | Medtronic, Inc. | $14.45 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH SPIRAL-Z Normalized: zenith spiral z |
Device | Cook Medical LLC | $14.34 | 2 | 2025 |
Source payment records
|
|||||
| FLOWRUNNER Normalized: flowrunner |
Device | Flowphysix Inc | $12.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 301 | 86 |
| Eliquis | Apixaban | 106 | 22 |
| Warfarin Sodium | Warfarin Sodium | 38 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 31 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 31 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | 23 |
| Prednisone | Prednisone | 19 | 14 |
| Xarelto | Rivaroxaban | 19 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 14 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $2,383.43 · 66 records | Endologix LLC | AFX2 Bifurcated Endograft System, ALPHAVAC, AURYON LASER SYSTEM 100-120 VAC, Alto Abdominal Stent Graft System, CARDIOSAVE RESCUE, CGuard Prime Carotid Stent System, CLOSURERFS, CLOT MANAGEMENT, CLOTTRIEVER BOLD CATHETER, COOK, CT THROMBECTOMY SYSTEM KIT, ELUVIA, ESPRIT, FLOWRUNNER, FLOWTRIEVER CATHETER, S, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABAHN VBX Balloon Expandable Endo, GRAFIX PL, ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM, Indigo System, Kerecis GraftGuide, Kerecis SurgiClose, PREVENA, Penumbra System, Progel Applicator Spray Tips, STRAVIX PL, Serrantor, V.A.C. GRANUFOAM, V.A.C. VERAFLO CLEANSE CHOICE, ZENITH, ZENITH ALPHA, ZENITH SPIRAL-Z, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error